Dr. Joseph Spann, MD

NPI: 1912910639
Total Payments
$15,607
2018 Payments
$4,689
Companies
1
Transactions
25
Medicare Patients
77
Medicare Billing
$8,116

Payment Breakdown by Category

Consulting$9,389 (60.2%)
Other$5,900 (37.8%)
Travel$317.64 (2.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $9,389 15 60.2%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $5,900 6 37.8%
Travel and Lodging $317.64 4 2.0%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $15,607 25 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2018 $4,689 9 Novartis Pharmaceuticals Corporation ($4,689)
2017 $10,918 16 Novartis Pharmaceuticals Corporation ($10,918)

All Payment Transactions

25 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
08/25/2018 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $800.00 General
Category: NEUROSCIENCE
08/25/2018 NOVARTIS PHARMACEUTICALS CORPORATION GILENYA (Drug) Consulting Fee Cash or cash equivalent $37.99 General
Category: NEUROSCIENCE
05/22/2018 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: NEUROSCIENCE
05/12/2018 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: NEUROSCIENCE
05/12/2018 NOVARTIS PHARMACEUTICALS CORPORATION GILENYA (Drug) Consulting Fee Cash or cash equivalent $52.87 General
Category: NEUROSCIENCE
04/16/2018 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: NEUROSCIENCE
04/05/2018 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: NEUROSCIENCE
02/13/2018 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: NEUROSCIENCE
02/13/2018 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $48.51 General
Category: NEUROSCIENCE
12/09/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: NEUROSCIENCE
11/09/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: NEUROSCIENCE
11/08/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: NEUROSCIENCE
11/02/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: NEUROSCIENCE
10/24/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $950.00 General
Category: NEUROSCIENCE
10/19/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: NEUROSCIENCE
03/23/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program Cash or cash equivalent $750.00 General
Category: NEUROSCIENCE
03/19/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program Cash or cash equivalent $750.00 General
Category: NEUROSCIENCE
03/19/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Travel and Lodging In-kind items and services $66.88 General
Category: NEUROSCIENCE
03/10/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program Cash or cash equivalent $150.00 General
Category: NEUROSCIENCE
02/26/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program Cash or cash equivalent $2,150.00 General
Category: NEUROSCIENCE
02/26/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Travel and Lodging In-kind items and services $74.90 General
Category: NEUROSCIENCE
02/04/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program Cash or cash equivalent $1,000.00 General
Category: NEUROSCIENCE
02/04/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Travel and Lodging In-kind items and services $66.18 General
Category: NEUROSCIENCE
01/04/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program Cash or cash equivalent $1,100.00 General
Category: NEUROSCIENCE
01/04/2017 Novartis Pharmaceuticals Corporation GILENYA (Drug) Travel and Lodging In-kind items and services $109.68 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 1 14 14 $4,438 $1,155
2020 3 63 74 $28,116 $6,960
Total Patients
77
Total Services
88
Medicare Billing
$8,116
Procedure Codes
4

All Medicare Procedures & Services

4 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 14 14 $4,438 $1,155 26.0%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 20 22 $13,552 $3,180 23.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 23 32 $10,144 $2,598 25.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 20 20 $4,420 $1,183 26.8%

About Dr. Joseph Spann, MD

Dr. Joseph Spann, MD is a Internal Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912910639.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Spann, MD has received a total of $15,607 in payments from pharmaceutical and medical device companies, with $4,689 received in 2018. These payments were reported across 25 transactions from 1 company. The most common payment nature is "Consulting Fee" ($9,389).

As a Medicare-enrolled provider, Spann has provided services to 77 Medicare beneficiaries, totaling 88 services with total Medicare billing of $8,116. Data is available for 2 years (2020–2021), covering 4 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Austin, TX
  • Active Since 08/14/2006
  • Last Updated 07/21/2022
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1912910639

Products in Payments

  • GILENYA (Drug) $15,607

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Austin